Top of this page
Skip navigation, go straight to the content

  • Sharing the good news…

    Posted by Antje Witte, Investor Relations 23-Jan-2012

    Where did the Christmas holidays go? Somehow it’s almost February already but at least January brought a major piece of good news: we won an award!

    Read more

  • Q3 financial results show UCB is on track

    Posted by Antje Witte, Investor Relations 27-Oct-2011

     

    Read more

  • UCB 'on the road again'

    Posted by Antje Witte, Investor Relations 13-Sep-2011

     

    Read more

  • UCB delivers strong results

    Posted by Antje Witte, Investor Relations 29-Jul-2011

      

    Read more

  • UCB off to good start in 2011

    Posted by Antje Witte, Investor Relations 29-Apr-2011

    Financial figures published on April, 28 reveal UCB got off to a strong start with total revenue increasing by 13% to €893 million in the first quarter of the year.


    Read more

  • 2010 Annual Report

    Posted by Antje Witte, Investor Relations 29-Apr-2011

    Annual Report shows UCB’s biopharma aspirations on track

    The 2010 Annual Report is now available on the UCB website. Offering more than just financial results, this year’s report highlights and analyses UCB’s 2010 activities as it advanced its goals of becoming the patient-centric biopharmaceutical leader.

    Read more